Brief: Acurx Pharmaceuticals To Discuss Fourth Quarter And Full Year 2022 Financial Results And Provide Business Update
06/03/2023 13:21
March 6 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS TO DISCUSS FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS AND PROVIDE BUSINESS UPDATE
Source text for Eikon: ID:nPn5cTnkba
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program